Fundamental Data for INBP

Integrated BioPharma, Inc. is a well-established biopharma company serving the varied needs of the nutraceutical, biotech and pharmaceutical industries. Through a number of wholly owned subsidiaries INB develops, manufactures and distributes, worldwide over 130 products.

# Employees: 108

Address: 201 ROUTE 22,HILLSIDE,NJ,USA

Phone: 9739260816

Fax: 973-926-1735

Website: www.integratedbiopharma.com

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

E. Gerald Kay (Chief Executive Officer)

Dina L. Masi (Chief Financial Officer)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 12/31/2012

Next Earnings Date(Expected): 5/20/2013

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.01)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 0

Learn to Profit from Analyst Estimates

Shares Performance

Period	INBP	Compare to S&P
YTD	25.00 %	14.63 %
4 Weeks	14.29 %	14.41 %
12 Weeks	25.00 %	20.80 %

Shares Information

Analyst Coverage: N

Avg Volume: 1532

Shares Outstanding: 21M

Market Cap: $0.00B

52 Week High: $0.26

52 Week Low: $0.03

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 INBP split by factor of 0.250

Earnings Performance

EPS Growth in Last Quarter: 160.00 %

EPS Growth in Last Year: 200.00 %

Sales Growth in Last Quarter: -12.81 %

Sales Growth in Last Quarter: 2.13 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010